News – Page 1104 – Endpoints News

Samsung Bioepis switches gears, moves from knockoffs to new drugs with fast-changing Takeda

8 years ago

Medivir out-licenses hep C drug to China’s Ascletis; Cellectis launches pioneering UCART123 US study

8 years ago

Biotech M&A barely showing sign of a pulse so far in 2017

8 years ago

Preemptive shaming assault on Novartis’ CAR-T pioneer underscores a disconnect on R&D costs

8 years ago

With CAR-T marketing looming, early study highlights potential of TCR engineering

8 years ago

Thomas Wynn makes the leap out of the NIH and into a lead discovery post for Pfizer

8 years ago

Watch out Tesaro, AstraZeneca and Merck get FDA OK for broad use of Lynparza

8 years ago

Pfizer's CD22-targeted cancer drug inotuzumab wins an accelerated OK at FDA

8 years ago

Arcus grabs US rights to a WuXi-built PD-1 as second wave of checkpoints builds

8 years ago

BlueRock expands Toronto ops; Unity brings B round to $151M; Novartis backs Altimmune's $15M raise

8 years ago

Atreca bags $35M B round for next-gen immuno-oncology drug pipeline

8 years ago

Price gouging on drugs? Shkreli's jury selection process reveals some deep public anger

8 years ago

Aerie boosted as Valeant's troubled Tampa facility looks like it's coming out of rehab

8 years ago

Top UCSF scientist Shaun Coughlin joins migration to Big Pharma, leaping to Novartis

8 years ago

Novo's semaglutide handily whips Eli Lilly's Trulicity in a PhIII diabetes showdown

8 years ago

J&J's Alex Gorsky reverses course and jumps ship — just as Trump scuttles top CEO groups

8 years ago

Takeda inks discovery pact with Stanford; Jounce taps Ariad vet Cole as new CBO

8 years ago

New study of FDA cites the flaws behind rapid-fire cancer drug OKs

8 years ago

Celgene-partnered Antengene preps new China deals as $21M round lands

8 years ago

Feds offer up a new bonus plan for the R&D work they often pay for

8 years ago

The big revamp at GlaxoSmithKline R&D includes a new collaboration on AI

8 years ago

With a big stake in hand, Samantha Du files for $115M IPO for Zai Lab

8 years ago

Bristol-Myers shares sink after another setback for its immuno-oncology franchise drugs

8 years ago

As Trump lashes out at Frazier again, J&J's Alex Gorsky says he's not abandoning president's council

8 years ago

First page Previous page 1101 1102 110311041105 1106 1107 Next page Last page